Andrew Zloza, MD, PhD, is the Section Chief of Surgical Oncology Research and a member of the Clinical Investigations and Precision Therapeutics Program at Rutgers Cancer Institute of New Jersey. He is also a tenure-track Assistant Professor in the Department of Surgery at Rutgers Robert Wood Johnson Medical School and the Founding Faculty Director of the Immune Monitoring Core at Rutgers Cancer Institute.